About
Infinity Group, established in 1993, is a pioneering force in cross-border innovation and investment. It has evolved from a traditional investment fund into a comprehensive technology investment group, managing US$2 billion in assets with 250 investments and 75 successful exits. The group specializes in connecting Israeli innovation with global markets, particularly strengthening Sino-Israeli cooperation. Infinity Group has established 23+ funds, incubators & accelerators in China, managing over $1.5 billion in assets. It has created strategic partnerships with leading institutions, including the China Development Bank and numerous provincial governments. Infinity was the first Israeli entity to establish a local Chinese fund and the first to lead an Israeli company to an IPO in China.
Portfolio
Investment activity
1 portfolio exit on record.
Portfolio by sector
Q&A
- What is Infinity China's primary investment focus by sector?
- Infinity China shows a strong focus on Health Tech & Life Sciences, with two portfolio companies in this sector and one exit. They also have one portfolio company in Industrial Technologies.
- Can you name a notable exit for Infinity China?
- In September 2018, Infinity China saw an exit with IOPtima, which was acquired by Chengdu Kanghong Pharmaceutical Group for $56M. IOPtima develops surgical ophthalmic laser devices.
- Which portfolio companies has Infinity China invested in recently?
- Infinity China has invested in NovaSight, which raised an A round of $38.88M, and Newsight Imaging, which raised an A round of $14.1M. Both companies were founded in 2016.
- What is the typical funding stage for Infinity China's investments?
- Infinity China has participated in one A Round and two B Rounds, indicating a focus on early to growth-stage investments.
- What is Infinity China's investment activity trend over time?
- Infinity China has shown consistent investment activity, with one new portfolio company added in November 2015, another in October 2019, and the most recent in March 2024.
- What is the business model of Infinity China's portfolio company, NovaSight?
- NovaSight, a portfolio company of Infinity China, operates with B2B, B2B2C, and B2C business models, focusing on eye-tracking based solutions for pediatric vision care.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 1993 |
|---|
Radar intelligence
Patents
| EPO | 10 |
|---|